Gene panel testing for hereditary breast cancer

Med J Aust 2016; 204 (5): 188-190.
Authors: Ingrid Winship and Melissa C Southey
“Inherited predisposition to breast cancer is explained only in part by mutations in the BRCA1 and BRCA2 genes. …New genetic technology allows a panel of multiple genes to be tested for mutations in a single test. This enables more women and their families to have risk assessment and risk management, in a preventive approach to predictable breast cancer. …Ethical issues warrant consideration, as multiple gene panel testing has the potential to identify secondary findings not originally sought by the test requested.”
Find abstract here.